Trial Profile
The effect of sitagliptin on serum PAI-1 concentration in type 2 diabetic patient.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Jun 2012 Actual end date (Mar 2012) added as reported by University Hospital Medical Information Network - Japan record.
- 03 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 03 Jun 2011 Planned initiation date (Dec 2012) added as reported by University Hospital Medical Information Network - Japan.